recommended for detection of MPDU1 of human origin by WB, IP, IF, IHC(P) and ELISA
Modification Notes
MPDU1 (Mannose-P-dolichol utilization defect 1 protein), also designated suppressor of Lec15 and Lec35 glycosylation mutation or SL15, mediates the transfer of glucose and mannose residues from Glc-P-Dol and Man-P-Dol to oligosaccharides. Defects in the MPDU1 gene result in a Type I congenital disorder of glycosylation CDG-If. Patients with CDG-If make incomplete lipid-linked oligosaccharides (LLO) and present with severe psychomotor retardation, seizures, failure to thrive, dry skin and scaling with erythroderma and impaired vision. Overexpression of GlcNAc-1-P transferase has been shown to impair the function of MPDU1, suggesting a form of pseudo-CDG-If.
Key Feature
Clonality
Polyclonal
Isotype
IgG
Host Species
Rabbit
Tested Applications
WBIPIFIHCELISA
WB:1:500~1:2000 IP:1:100~1:500 IF:1:200~1:500 IHC:1:50~1:200 Notes:Optimal dilutions/concentrations should be determined by the researcher.
Species Reactivity
HumanMouseRat
Concentration
1mg/ml
Purification
Affinity purified
Target Information
Alternative Names
recommended for detection of MPDU1 of human origin by WB IP IF IHC(P) and ELISA
Tissue Specificity
recommended for detection of MPDU1 of human origin by WB, IP, IF, IHC(P) and ELISA